1. Medtech Insight

Abbott’s Lingo Biowearable For Consumers Debuts In The UK As Libre Momentum Continues

 
• By Marion Webb

Abbott launched its first biowearable for consumers in the UK with plans to expand in Europe and the US. Analysts are optimistic about continued growth of Libre FreeStyle amid drivers such as CGM adoption by non-insulin users, expected 15-day sensor, streaming capability and integration with Tandem insulin pump.

Lingo
• Source: Abbott

[Editor's Note:This article was updated on 26 July with new information about the pricing for Lingo in the UK.] 

Abbott's long-awaited biowearable made its

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diabetic Care

More from Device Area